PDCD1 and neoplasm: In summary, this study indicates that DLBCL patients with high PD‐1 expression on CD4+ T cells might damage T‐cell function, thereby leading to poor prognosis, while PD‐1 expression on peripheral blood CD4+ T cells does not reflect PD‐1 expression on cells in the tumor microenvironment.